Good article on Bloomberg today around big pharma/biotech buyouts and takeovers;
https://www.bloomberg.com/opinion/articles/2019-12-16/amarin-fish-oil-heart-drug-good-news-is-already-priced-in-stock?srnd=premium-asia
Relates to a bio-pharmaceutical company (Amarin) that's managed to patent a fish oil supplement (Vascepa) in pill form as a heart attack and stroke preventative.
Interesting points around restricted FDA approval, and a comment that insurance reimbursal wasn't assured, despite the low cost, because of the numbers of people likely to be taking it.
Good article on Bloomberg today around big pharma/biotech...
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
24.0¢ |
Change
0.010(4.35%) |
Mkt cap ! $85.70M | |||
| Open | High | Low | Value | Volume |
| 24.0¢ | 25.0¢ | 24.0¢ | $160.9K | 661.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 31284 | 24.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 25.0¢ | 50728 | 3 |
View Market Depth
| Last trade - 11.45am 20/08/2024 (20 minute delay) ? |
| PAR (ASX) Chart |